Johnson & Johnson Innovation announces extension of partnering office at Monash University
Date Posted – 15 July 2021 Victorian State Government extends financing of JJIPO@Monash for an additional two years Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare…
Investors buoyed by positive data for Immutep’s immunotherapy
Date Posted – 7 June 2021 Small cap immunotherapy biotech Immutep is a step closer to commercialising its leading drug candidate, “efti”, after releasing promising data showing the effectiveness of the drug in treating various types of lung,…
Falling Walls Lab is coming to Victoria!
Date Posted: 1 June 2021 Closing date: 28 June 2021 Falling Walls Lab asks one question Which are the next walls to fall? veski and Deakin University are hosting the Falling Walls Lab Victoria in 2021 – a…
Intellectual Property and Marketing Campaigns
Date Posted – 1 June 2021 by Katarina Klaric, Principal, Stephens Lawyers & Consultants. Marketing and advertising campaigns can play a significant role in building brand awareness, increasing sales and revenue and enhancing the value of company or…
Advertising Compliance: Therapeutic Goods Act and Australian Consumer Law
Date Posted – 1 June 2021 by Katarina Klaric, Principal, Stephens Lawyers & Consultants Knowing the advertising laws that apply to the marketing and advertising of a particular product or services is critical to avoid breaches resulting…
Positive FDA meetings enable Neuren to proceed with INDs for three Phase 2 trials
Date Posted – 1 June 2021 Highlights: • Clear and constructive guidance received from pre-IND meetings with the FDA Office of Neuroscience for Phase 2 clinical trials of NNZ-2591 in Phelan-McDermid, Angelman and Pitt Hopkins syndromes • Positive…
ReNerve and VivaZome Enter Collaboration in Spinal Cord Repair
Date Posted – 25 May 2021 ReNerve Ltd (ReNerve) and VivaZome Therapeutics Pty Ltd (VivaZome) today announced that they have entered a collaboration to combine their leading scaffold and exosome technologies, skills and experience…
Monash University – World #2 launches new Master of Pharmaceutical Science
Date Posted – 25 May 2021 Monash University has launched a new postgraduate degree to address a major skills shortage in the Australian pharmaceutical sector and its allied industries. The Master of Pharmaceutical Science will be offered by…
Rhinomed Rhinoswab Secures European CE Mark
Date Posted – 20 May 2021 Rhinomed Limited (ASX:RNO OTCQB:RHNMF), a leader in wearable nasal and respiratory technology, is pleased to announce it has been advised by Medical Device Safety Service GmbH (MDSS) that an Authorized Representative’s Mandate…
New antimicrobial surface reduces bacteria build-up on medical instruments – Monash University
Date Posted – 20 May 2021 Patient infection from urinary catheters are a global health concern. In a world-first, Monash University researchers have developed a new 3D antimicrobial surface to reduce bacterial build-up. The study saw a reduction…
Silicosis research awarded more than $1.6 million – Hudson Institute of Medical Research and Monash University
Date Posted – 20 May 2021 A deadly and incurable lung disease afflicting Australian tradies could be prevented from progressing and successfully treated, following a multi-million federal funding boost to silicosis research. Hudson Institute of Medical Research and…
Victorian budget invests in the health of Generation Victoria – MCRI
Date Posted – 20 May 2021 The Murdoch Children’s Research Institute (MCRI) welcomes the additional investment from the Victorian Government of $14 million AUD to support its innovative Generation Victoria (GenV) research project. The first project of its kind in Australia, GenV…
